<!DOCTYPE html>
<html>
	<head>
	<meta charset="utf-8">
	<meta name="viewport" content="width=device-width,initial-scale=1.0">

	<title>Text and Image</title>

	<!-- Website/Theme CSS -->
	<link rel="stylesheet" href="css/screen.min.css">
	<!--<link rel="stylesheet" href="css/screen.min.css">-->
	<!--<link rel="stylesheet" href="http://oncotherics.com/wp/wp-content/themes/biothemes/css/screen-oncotherics.min.css">-->
 	
 	<!-- Pattern library CSS -->
	<link rel="stylesheet" href="css/library.css">

	<!-- This space intentionally left blank. Put your custom web-served fonts here -->
	<!-- Web Font Loader -->
	<script src="https://ajax.googleapis.com/ajax/libs/webfont/1.6.26/webfont.js"></script>
	<script>
	  WebFont.load({
	    google: {
	      families: ['Encode+Sans:300,700,900'],
	    }
	  });
	</script>

</head>



	<body>
  		<h1>Pattern Sample: Text and Image</h1>

<article class="block text-image position--left width--third">
	<div class="block--text">
		<h2>Sed ullamcorper morbi tincidunt ornare massa</h2>
		<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Mauris nunc congue nisi vitae suscipit tellus mauris. Justo eget magna fermentum iaculis. Ut eu sem integer vitae justo. Elit ullamcorper dignissim cras tincidunt lobortis feugiat vivamus at. Nisl rhoncus mattis rhoncus urna. Imperdiet sed euismod nisi porta lorem. Augue eget arcu dictum varius duis at consectetur. Lacus vel facilisis volutpat est velit.</p>
	</div><!-- .block--text -->

	<div class="block--image">
		<img src="http://oncotherics.dev/wp-content/uploads/2017/10/OCT-and-UHN.jpg" alt="OncoTherics and UHN sign MoU. Left to right are Bharti Ranawaya (BDM, UHN), Mark Taylor (Director of Commercialisation, UHN), Stefan Ogrodzinski (CEO OncoTherics), John Reid (Director TD&amp;C, UHN) and Laurence Patterson (Chair, SAB OncoTherics).">
	</div><!-- .block--image -->
</article>
		
<article class="block text-image position--right width--third">
	<div class="block--text">
		<h2>Sed ullamcorper morbi tincidunt ornare massa</h2>
		<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Mauris nunc congue nisi vitae suscipit tellus mauris. Justo eget magna fermentum iaculis. Ut eu sem integer vitae justo. Elit ullamcorper dignissim cras tincidunt lobortis feugiat vivamus at. Nisl rhoncus mattis rhoncus urna. Imperdiet sed euismod nisi porta lorem. Augue eget arcu dictum varius duis at consectetur. Sed ullamcorper morbi tincidunt ornare massa. Lacus vel facilisis volutpat est velit.</p>
	</div><!-- .block--text -->

	<div class="block--image">
		<img src="http://oncotherics.dev/wp-content/uploads/2017/10/OCT-and-UHN.jpg" alt="OncoTherics and UHN sign MoU. Left to right are Bharti Ranawaya (BDM, UHN), Mark Taylor (Director of Commercialisation, UHN), Stefan Ogrodzinski (CEO OncoTherics), John Reid (Director TD&amp;C, UHN) and Laurence Patterson (Chair, SAB OncoTherics).">
	</div><!-- .block--image -->
</article><!-- .block.text-image -->

<article class="block text-image position--left width--twothirds">
	<div class="block--text">
		<h2>Sed ullamcorper morbi tincidunt ornare massa</h2>
		<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Mauris nunc congue nisi vitae suscipit tellus mauris. Justo eget magna fermentum iaculis. Ut eu sem integer vitae justo. Elit ullamcorper dignissim cras tincidunt lobortis feugiat vivamus at. Nisl rhoncus mattis rhoncus urna. Imperdiet sed euismod nisi porta lorem. Augue eget arcu dictum varius duis at consectetur. Sed ullamcorper morbi tincidunt ornare massa. Lacus vel facilisis volutpat est velit.</p>
	</div><!-- .block--text -->

	<div class="block--image">
		<img src="http://oncotherics.dev/wp-content/uploads/2017/10/OCT-and-UHN.jpg" alt="OncoTherics and UHN sign MoU. Left to right are Bharti Ranawaya (BDM, UHN), Mark Taylor (Director of Commercialisation, UHN), Stefan Ogrodzinski (CEO OncoTherics), John Reid (Director TD&amp;C, UHN) and Laurence Patterson (Chair, SAB OncoTherics).">
	</div><!-- .block--image -->
</article><!-- .block.text-image -->

<article class="block text-image position--right width--half">
	<div class="block--text">
		<h2>Sed ullamcorper morbi tincidunt ornare massa</h2>
		<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Mauris nunc congue nisi vitae suscipit tellus mauris. Justo eget magna fermentum iaculis. Ut eu sem integer vitae justo. Elit ullamcorper dignissim cras tincidunt lobortis feugiat vivamus at. Nisl rhoncus mattis rhoncus urna. Imperdiet sed euismod nisi porta lorem. Augue eget arcu dictum varius duis at consectetur. Sed ullamcorper morbi tincidunt ornare massa. Lacus vel facilisis volutpat est velit.</p>
	</div><!-- .block--text -->

	<div class="block--image">
		<img src="http://oncotherics.dev/wp-content/uploads/2017/10/OCT-and-UHN.jpg" alt="OncoTherics and UHN sign MoU. Left to right are Bharti Ranawaya (BDM, UHN), Mark Taylor (Director of Commercialisation, UHN), Stefan Ogrodzinski (CEO OncoTherics), John Reid (Director TD&amp;C, UHN) and Laurence Patterson (Chair, SAB OncoTherics).">
	</div><!-- .block--image -->
</article><!-- .block.text-image -->

<article class="block text-image position--left width--third">
	<div class="block--text">
		<h2>Sed ullamcorper morbi tincidunt ornare massa</h2>
		<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Mauris nunc congue nisi vitae suscipit tellus mauris. Justo eget magna fermentum iaculis. Ut eu sem integer vitae justo. Elit ullamcorper dignissim cras tincidunt lobortis feugiat vivamus at. Nisl rhoncus mattis rhoncus urna. Imperdiet sed euismod nisi porta lorem. Augue eget arcu dictum varius duis at consectetur. Sed ullamcorper morbi tincidunt ornare massa. Lacus vel facilisis volutpat est velit.</p>
	</div><!-- .block--text -->

	<div class="block--image">
		<img src="http://oncotherics.dev/wp-content/uploads/2017/10/OCT-and-UHN.jpg" alt="OncoTherics and UHN sign MoU. Left to right are Bharti Ranawaya (BDM, UHN), Mark Taylor (Director of Commercialisation, UHN), Stefan Ogrodzinski (CEO OncoTherics), John Reid (Director TD&amp;C, UHN) and Laurence Patterson (Chair, SAB OncoTherics).">
	</div><!-- .block--image -->
</article><!-- .block.text-image -->


<a href="/" title="A helpful back button!">Back to the primer</a>
	</body>
</html>